F. Hoffmann-La Roche Ltd.

In News

Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD - Yahoo Finance Singapore

Yahoo Finance Singapore - Apr 21, 2026

FDA accepts application for Roche’s Gazyva/Gazyvaro for the treatment of the most common form of lupus - GlobeNewswire

GlobeNewswire - Apr 21, 2026

Pharmacogenomics Market Leading Companies | F. Hoffmann-la - openPR.com

openPR.com - Apr 21, 2026

China's Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche - Reuters

Reuters - Oct 16, 2025

F. Hoffmann-La Roche Ltd - Via Ritzau

Via Ritzau - Apr 13, 2026

Roche signs agreement to acquire 89bio in $2.4bn deal - Pharmaceutical Technology

Pharmaceutical Technology - Sep 18, 2025

Roche Gives Up On Bid To Patent Cancer Fusion Gene Tool - Law360

Law360 - Mar 03, 2026

Change to the Roche Enlarged Corporate Executive Committee - GlobeNewswire

GlobeNewswire - Feb 17, 2026

Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply - GlobeNewswire

GlobeNewswire - Mar 30, 2026

Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development - Yahoo Finance

Yahoo Finance - Mar 23, 2026

Roche announces positive Phase II results for petrelintide, an amylin analog developed for people living with overweight and obesity - Yahoo Finance

Yahoo Finance - Mar 05, 2026

Roche launches NVIDIA AI factory to accelerate the development of new therapeutics and diagnostics solutions - GlobeNewswire

GlobeNewswire - Mar 16, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment